Advisor Partners II’s Meridian Bioscience Inc VIVO Stock Holding History

Advisor Partners II’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-18,663	Closed	-$620K	–	1056
2022 Q4	$620K	Sell	18,663 -520	-3%	-$16.7K	0.04%	467
2022 Q3	$605K	Buy	+19,183	New	+$621K	0.05%	409

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Advisor Partners II's VIVO Position: Q1 2023 in Review

Advisor Partners II sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 18,663 shares — an estimated $620K sold.

Advisor Partners II first reported a position in VIVO in Q3 2022 and held it in 2 quarters. The position peaked at $620K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Advisor Partners II reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Advisor Partners II sold 18,663 Meridian Bioscience Inc shares in Q1 2023, an estimated $620K.
Advisor Partners II first reported a position in Meridian Bioscience Inc in Q3 2022 and held it in 2 quarters.
Advisor Partners II's Meridian Bioscience Inc position peaked at $620K in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Advisor Partners II's 13F filing for Q1 2023, filed 15 May 2023.